Management of concomitant risk

Megan E. Miller; Sarah M. Nielsen; Swati A. Kulkarni

doi:10.1007/978-1-4614-5891-3_10

Management of concomitant risk

Megan E. Miller^*, Sarah M. Nielsen, Swati A. Kulkarni

^*Corresponding author for this work

Surgery, Breast Surgery Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Breast cancer risk has been well-characterized for a number of genetic syndromes including carriers of BRCA1/BRCA2, TP53, and PTEN. This chapter will focus primarily on the risk of developing other malignancies in those individuals or family members with a genetic predisposition to breast cancer. Screening protocols and risk reduction strategies will also be reviewed for individual malignancies where appropriate (Table 10.1).

Original language	English (US)
Title of host publication	Management of the Patient at High Risk for Breast Cancer
Publisher	Springer New York
Pages	141-154
Number of pages	14
ISBN (Electronic)	9781461458913
ISBN (Print)	1461458900, 9781461458906
DOIs	https://doi.org/10.1007/978-1-4614-5891-3_10
State	Published - Nov 1 2013

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4614-5891-3_10

Fingerprint Dive into the research topics of 'Management of concomitant risk'. Together they form a unique fingerprint.

Cite this

Miller, M. E., Nielsen, S. M., & Kulkarni, S. A. (2013). Management of concomitant risk. In Management of the Patient at High Risk for Breast Cancer (pp. 141-154). Springer New York. https://doi.org/10.1007/978-1-4614-5891-3_10

@inbook{400d63dcb81d402d97e622cffd68b440,

title = "Management of concomitant risk",

abstract = "Breast cancer risk has been well-characterized for a number of genetic syndromes including carriers of BRCA1/BRCA2, TP53, and PTEN. This chapter will focus primarily on the risk of developing other malignancies in those individuals or family members with a genetic predisposition to breast cancer. Screening protocols and risk reduction strategies will also be reviewed for individual malignancies where appropriate (Table 10.1).",

author = "Miller, {Megan E.} and Nielsen, {Sarah M.} and Kulkarni, {Swati A.}",

year = "2013",

month = nov,

day = "1",

doi = "10.1007/978-1-4614-5891-3_10",

language = "English (US)",

isbn = "1461458900",

pages = "141--154",

booktitle = "Management of the Patient at High Risk for Breast Cancer",

publisher = "Springer New York",

}

TY - CHAP

T1 - Management of concomitant risk

AU - Miller, Megan E.

AU - Nielsen, Sarah M.

AU - Kulkarni, Swati A.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Breast cancer risk has been well-characterized for a number of genetic syndromes including carriers of BRCA1/BRCA2, TP53, and PTEN. This chapter will focus primarily on the risk of developing other malignancies in those individuals or family members with a genetic predisposition to breast cancer. Screening protocols and risk reduction strategies will also be reviewed for individual malignancies where appropriate (Table 10.1).

AB - Breast cancer risk has been well-characterized for a number of genetic syndromes including carriers of BRCA1/BRCA2, TP53, and PTEN. This chapter will focus primarily on the risk of developing other malignancies in those individuals or family members with a genetic predisposition to breast cancer. Screening protocols and risk reduction strategies will also be reviewed for individual malignancies where appropriate (Table 10.1).

UR - http://www.scopus.com/inward/record.url?scp=84929579821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929579821&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5891-3_10

DO - 10.1007/978-1-4614-5891-3_10

M3 - Chapter

AN - SCOPUS:84929579821

SN - 1461458900

SN - 9781461458906

SP - 141

EP - 154

BT - Management of the Patient at High Risk for Breast Cancer

PB - Springer New York

ER -